Screening for Preeclampsia With Various Markers in Low-risk Pregnancy Populations
Screening Models for Early Detection of Late-onset Preeclampsia With Various Markers in Low-risk Pregnancy Populations
1 other identifier
observational
262
0 countries
N/A
Brief Summary
For the prediction of late-onset preeclampsia (PE) in low risk women, the investigators established a cut-off value for sFlt-1/PlGF ratio and evaluated the combination models of Elecys, second trimester uterine artery (UtA) doppler, and fetoplacental proteins for Down syndrome screening.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2009
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2011
CompletedFirst Submitted
Initial submission to the registry
July 19, 2012
CompletedFirst Posted
Study publicly available on registry
July 25, 2012
CompletedJuly 25, 2012
July 1, 2012
2.3 years
July 19, 2012
July 24, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
identification of patients at risk for late-onset preeclampsia with sFlt-1/PlGF ratio
at delivery
Secondary Outcomes (1)
identification of patients at risk for late-onset preeclampsia with combined biochemical markers
at delivery
Eligibility Criteria
low risk women who had not a risk factor of preeclampsia.
You may qualify if:
- Women considered as a potential participant in this research were patients regularly visited at the prenatal care of Cha hospital in Seoul, Korea
You may not qualify if:
- early onset and cases not to measure the sFlt/PlGF ratio and other markers
- twin pregnancy
- Chronic hypertension
- prior history of preeclampsia
- pregestational diabetes mellitus
- gestational diabetes mellitus
- patients delivered before 35 weeks of gestation
- preeclamptic patients with onset before 35 weeks of gestation
- patients with body mass index 25kg/m2 or greater
- maternal age 40 years older
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- CHA Universitylead
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- professor
Study Record Dates
First Submitted
July 19, 2012
First Posted
July 25, 2012
Study Start
August 1, 2009
Primary Completion
December 1, 2011
Study Completion
December 1, 2011
Last Updated
July 25, 2012
Record last verified: 2012-07